ML

Mineralys Therapeutics IncNASDAQ MLYS Stock Report

Last reporting period 30 Sep, 2023

Updated 19 Nov, 2024

Last price

Market cap $B

0.72

Micro

Exchange

XNAS - Nasdaq

View Section: Price ratios

Mineralys Statements

ML

Data from Mineralys`s earning releases including common size income statement and balance sheet.

Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.

Key Information:

Report currency:

USD - US dollar

Last reporting period:

30 Sep, 2023

Next reporting period:

29 Dec, 2023

Report frequency:

Quarterly

Earnings release date:

11 Nov, 2024

Expected release date:

11 Nov, 2024

Mineralys Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

B

M

USD (except Earnings per share)

Financial

Revenue


Cost of sales


Gross profit


Research and development


Selling, general and administrative


Total operating expenses


Operating income


Interest expense


Other income


Income before tax


Provision for income taxes


Net income


Diluted earnings per share


Shares outstanding after dilution


2023-09-30
%

100

0

0

22.499

0

3.774

0

26.273

67 %

0

-26.273

-67 %

0

3.513

0

0

-22.76

-87.5 %

0

0

-22.76

-87.5 %

0

-0.57

39.931

2023-06-30
%

100

0

0

11.884

0

3.851

0

15.735

5.3 %

0

-15.735

-5.3 %

0

3.593

0

0.001

0

-12.141

3.7 %

0

0

-12.141

3.7 %

0

-0.305

39.755

2023-03-31
%

100

0

0

12.293

0

2.645

0

14.938

49.3 %

0

-14.938

-49.3 %

0

2.329

0

0.001

0

-12.608

-39 %

0

0

-12.608

-39 %

0

-0.309

40.857

2022-12-31
%

100

0

0

7.818

0

2.19

0

10.008

-53.4 %

0

-10.008

53.4 %

0

0.935

0

0

-9.073

56.2 %

0

0

-9.073

56.2 %

0

-0.245

37.057

2022-09-30
%

100

0

0

18.432

0

3.039

0

21.471

0

-21.471

0

0.741

0

0.004

0

-20.726

0

0

-20.726

0

-0.559

37.057

View Section: Balance Sheet